TCTHPV―DNA联合阴道镜检查在宫颈病变诊断中应用价值.docVIP

TCTHPV―DNA联合阴道镜检查在宫颈病变诊断中应用价值.doc

此“医疗卫生”领域文档为创作者个人分享资料,不作为权威性指导和指引,仅供参考
  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
TCTHPV―DNA联合阴道镜检查在宫颈病变诊断中应用价值

TCTHPV―DNA联合阴道镜检查在宫颈病变诊断中应用价值   【摘要】目的:探讨TCT、HPV-DNA联合阴道镜检查在宫颈病变诊断中的应用价值。方法:选取2013年3月至2015年5月在我院同时行TCT、HPV-DNA及阴道镜检查的650例患者作为研究对象,对其中1项或以上检查异常者行病理活检,以病理学分级为标准分析诊断结果。结果:650例受检者中TCT阳性102例,其中ASCUS 80例,LSIL 15例,HSIL 6例,SCC 1例,HBV-DNA阳性40例,阴道镜阳性58例;TCT阳性病理活检结果为CINⅠ 16例,CINⅡ 10例,CINⅢ 4例,浸润癌2例;TCT、HPV-DNA联合阴道镜检查诊断CINⅠ、Ⅱ、Ⅲ准确率明显高于TCT联合HPV-DNA,差异有统计学意义(P0.05)。结论:TCT、HPV-DNA联合阴道镜检查是一种高效、快速的宫颈癌筛查方式,可为宫颈癌的临床诊断提供依据,在临床上具有重要应用价值。   【关键词】 液基细胞学检查; 人乳头瘤病毒;阴道镜;宫颈病变   Application value of TCT, HPV-DNA combined with vaginal examination in diagnosis of cervical lesionsQIN Yingming, ZHANG Xiuju, WANG Wei, YUE Li. Department of Obstetrics and Gynecology, Bazhong Traditional Chinese Medicine Hospital, Bazhong 636000, Sichuan, China   【Abstract】Objectives: To investigate the application value of TCT, HPV-DNA combined with vaginal examination in diagnosis of cervical lesions. Methods: 650 patients received TCT, HPV-DNA and vaginal examination in our hospital from March 2013 to May 2015 were selected. Pathological biopsy was performed on patients with 1 or more abnormal diagnosis results. Diagnosis results were analyzed with the pathological grade. Results: There were 102 patients with positive TCT result in 650 cases, including 80 cases with ASCU, 15 cases with LSIL, 6 cases with HSIL and 1 cases with SCC; 40 patients with positive HPV-DNA test result were found; 58 patients were found with positive colposcopic result. Among the patients with positive TCT result, there were 16 patients with CIN I, 10 patients with CIN II, 4 cases with CIN III and 2 patients with invasive carcinoma; The accuracy of TCT, HPV-DNA combined with vaginal examination in diagnosis of CIN I, II and III was significantly higher than that in TCT and HPV-DNA, with statistically significant difference (P0.05). Conclusion: The TCT, HPV-DNA combined with vaginal examination is an effective and fast screening method for cervical cancer, which can provide the basis for clinical diagnosis of cervical cancer and has impor

文档评论(0)

130****9768 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档